New York, December 29, 2023 – 2023 was a year filled with significant developments in emerging stocks, featuring a wide range of topics from clinical updates and strategic partnerships to earnings reports. Notable stories include Oncocyte’s initiation of the FDA submission process for its kidney transplant monitoring test, SKYX’s partnership with Kichler, and Soluna’s robust Q3 earnings. The year also saw engaging discussions on unique topics like full moon trading, Thanksgiving strategies, and the ever-popular cheeseburger economics.
Below is a summary of PRISM MarketView’s top articles from 2023, showcasing the market’s vibrancy and the diversity of reader interests:
OncoCyte (Nasdaq:OXC) began the FDA process for its VitaGraft kidney transplant assays, with PRISM Biotech Editor Catie Corcoran offering insights into this breakthrough in precision diagnostics.
SKY Technologies (Nasdaq:SKYX) expands in the lighting and ceiling fan market with its advanced and smart technology products.
Markets Editor Ashlee Vogenthaler combines humor with practical tips for Thanksgiving, offering both culinary and investment suggestions.
PRISM MarketView’s analysis of three small-cap stocks provides valuable insights for investors eyeing this segment during recessionary periods.
Cassava Sciences (Nasdaq: SAVA) reports encouraging safety reviews of simufilam, its candidate for Alzheimer’s treatment.
An exploration into the strategy of trading based on the moon’s phases and its effectiveness.
Quoin Pharmaceuticals (Nasdaq:QNRX) shows promising results in its Netherton Syndrome trial and strategic global expansion.
Catie Corcoran covers emerging drug delivery technology company Lexaria Bioscience (Nasadq:LEXX), as they look to enter the $18.75b GLP-1 market.
Soluna Holdings (Nasdaq:SLNH) experiences a positive market reaction following its strong financial performance in the third quarter.
Ashlee Vogenthaler mixes fun facts and insight into the world of cheeseburgers and their market relevance.
About PRISM MarketView:
Established in 2020, PRISM MarketView is dedicated to the monitoring and analysis of small cap stocks in burgeoning sectors. We deliver up-to-the-minute financial market news, provide comprehensive investor tools and foster a dynamic investor community. Central to our offerings are proprietary indexes that observe emerging sectors, including biotech, clean energy, next-generation tech, medical devices and beyond. Visit us at prismmarketview.com and follow us on Twitter.
PRISM MarketView does not provide investment advice.